Interventional Oncology Devices – Market Insights – United States
Despite the short-term challenges posed by the COVID-19 pandemic, the US market for interventional oncology devices will grow moderately through 2031. This will be driven largely by the expanding treatable patient populations, an increasing shift towards higher-priced technologies such as radioembolization, and growing physician acceptance of interventional oncology procedures.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2031.
The COVID-19 pandemic had short term consequences on the interventional oncology device market.
To what extent did COVID-19 affect the different procedure types in the interventional oncology market?
How will procedure volume recover over the forecast period?
The adoption of different ablation modalities have shifted in recent years.
How has the adoption of cryoablation changed the market dynamics in the microwave and RF ablation device categories?
In which indications will each modality experience the fastest growth?
What is the growth and adoption of IRE within the market and will this new technology overtake some of the existing product categories?
Radioembolization spheres continue to represent the largest segment of the interventional oncology device market.
What is the current adoption rate of radioembolization spheres and what can drive further penetration of this technology over the forecast period?
How is the adoption of DEBs and radioembolization spheres affected by recent clinical trials?
Table of contents
- Interventional Oncology Devices - Market Insights - United States
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Factors Impacting the Interventional Oncology Device Market, by Product Type, US
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132031
- Interventional Oncology Device Market Landscape, US (USD), 2021 and 2031
- Competitive Highlights
- Competitive Factors and Strategies, by Product Type, US
- Interventional Oncology Device Revenue Market Share Rankings, by Product Type, US, 2021
- Companies Mentioned
- Market Developments
- Recent Events in the Interventional Oncology Device Market, US
- Key Clinical Trials in the Interventional Oncology Device Market, US
- Emerging Products for the Interventional Oncology Device Market, US
- Procedures Covered
- Interventional Oncology Procedures Covered, US
- Products Covered
- Interventional Oncology Products Covered, US
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Interventional Oncology Device Market, US
- Major Market Forecast Changes and Assumptions
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132031 (Excluding COVID-19 Impact)
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132031 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Interventional Oncology Device Market, US
- COVID-19 Financial Impact and Competitor Insights
- Market Impact
- Interventional Oncology Device Market
- Market Highlights
- Factors Impacting the Interventional Oncology Device Market, by Product Type, US
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Interventional Oncology Procedures, by Procedure Type, US, 2019u20132031
- Interventional Oncology Procedures, by Indication, US, 2019u20132031
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132031
- Interventional Oncology Device Market Growth, by Product Type, US, 2020u20132031
- Competitive Highlights
- Market Shares
- Interventional Oncology Device Revenue Market Shares, US, 2021
- Interventional Oncology Device Revenue Market Shares, by Product Type, US, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, US
- Market Developments
- Recent Events in the Interventional Oncology Device Market, US
- Key Clinical Trials in the Interventional Oncology Device Market, US
- Emerging Products for the Interventional Oncology Device Market, US
- Market Highlights
- Ablation Device Market
- Market Highlights
- Ablation Device Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Ablation Procedures, by Indication, US, 2019u20132031
- Ablation Procedures, by Product Type, US, 2019u20132031
- Primary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132031
- Secondary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132031
- Kidney Cancer Ablation Procedures, by Procedure Type, US, 2019u20132031
- Lung Cancer Ablation Procedures, by Procedure Type, US, 2019u20132031
- Bone Cancer Ablation Procedures, by Procedure Type, US, 2019u20132031
- Pancreatic & Pelvic Cancer Ablation Procedures, by Procedure Type, US, 2019u20132031
- Ablation Disposables Market, by Product Type, US (USD), 2019u20132031
- Ablation Disposables Market Growth, by Product Type, US, 2020u20132031
- Ablation Capital Equipment Market, by Product Type, US (USD), 2019u20132031
- Ablation Capital Equipment Market Growth, by Product Type, US, 2020u20132031
- RF Ablation Procedures, by Indication, US, 2019u20132031
- RF Ablation Device Market, by Component, US (USD), 2019u20132031
- RF Ablation Device Market Growth, by Component, US, 2020u20132031
- Microwave Ablation Procedures, by Indication, US, 2019u20132031
- Microwave Ablation Device Market, by Component, US (USD), 2019u20132031
- Microwave Ablation Device Market Growth, by Component, US, 2020u20132031
- Cryoablation Procedures, by Indication, US, 2019u20132031
- Cryoablation Device Market, US (USD), 2019u20132031
- Cryoablation Device Market Growth, US, 2020u20132031
- IRE Ablation Procedures, by Indication, US, 2019u20132031
- IRE Ablation Device Market, US (USD), 2019u20132031
- IRE Ablation Device Market Growth, by Component, US, 2020u20132031
- Competitive Highlights
- Market Shares
- Ablation Device Revenue Market Shares, US, 2021
- Ablation Device Revenue Market Shares, by Product Type, US, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, US
- Market Highlights
- Embolization Particle Market
- Market Highlights
- Embolization Particle Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Embolization Particle Procedures, by Indication, US, 2019u20132031
- Embolization Particle Procedures, by Product Type, US, 2019u20132031
- Primary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132031
- Secondary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132031
- Kidney Cancer Embolization Particle Procedures, US, 2019u20132031
- Embolization Particle Market, by Product Type, US (USD), 2019u20132031
- Embolization Particle Market Growth, by Product Type, US, 2020u20132031
- PVA Particle Procedures, by Indication, US, 2019u20132031
- PVA Particle Market, US (USD), 2019u20132031
- Microsphere Procedures, by Indication, US, 2019u20132031
- Microsphere Market, US (USD), 2019u20132031
- DEB Procedures, by Indication, US, 2019u20132031
- DEB Market, US (USD), 2019u20132031
- Radioembolization Procedures, by Indication, US, 2019u20132031
- Radioembolization Sphere Market, US (USD), 2019u20132031
- Competitive Highlights
- Market Shares
- Embolization Particle Revenue Market Shares, US, 2021
- Embolization Particle Revenue Market Shares, by Product Type, US, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, US
- Market Highlights
- Accessory Device Market
- Market Highlights
- Accessory Device Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Accessory Device Market, by Product Type, US (USD), 2019u20132031
- Accessory Device Market Growth, by Product Type, US, 2020u20132031
- Competitive Highlights
- Market Shares
- Accessory Device Revenue Market Shares, US, 2021
- Accessory Devices Revenue Market Shares, by Product Type, US, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, US
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Xi Chen is a manager on the Medtech Insights team at Clarivate and currently serves as the in-house expert in general surgery, gastroenterology, ENT, and robotic surgery markets. Xi has been instrumental in improving the team’s market modeling capabilities and has also helped broaden the team’s expertise in leveraging medical claims and hospital purchase order data to perform market sizing and competitive analysis. Xi has been featured in several industry publications, particularly for his expertise in the robotic surgery market. Xi holds a Ph.D. in Biomedical Engineering from the University of Toronto.